NL1028599A1 - Verbindingen voor de behandeling van ziekten. - Google Patents
Verbindingen voor de behandeling van ziekten.Info
- Publication number
- NL1028599A1 NL1028599A1 NL1028599A NL1028599A NL1028599A1 NL 1028599 A1 NL1028599 A1 NL 1028599A1 NL 1028599 A NL1028599 A NL 1028599A NL 1028599 A NL1028599 A NL 1028599A NL 1028599 A1 NL1028599 A1 NL 1028599A1
- Authority
- NL
- Netherlands
- Prior art keywords
- diseases
- compounds
- treatment
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/65—One oxygen atom attached in position 3 or 5
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP04290770 | 2004-03-23 | ||
| EP04290770 | 2004-03-23 | ||
| US62502104P | 2004-11-03 | 2004-11-03 | |
| US62502104 | 2004-11-03 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NL1028599A1 true NL1028599A1 (nl) | 2005-09-26 |
| NL1028599C2 NL1028599C2 (nl) | 2006-01-03 |
Family
ID=34961254
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NL1028599A NL1028599C2 (nl) | 2004-03-23 | 2005-03-22 | Verbindingen voor de behandeling van ziekten. |
Country Status (5)
| Country | Link |
|---|---|
| AR (1) | AR048322A1 (nl) |
| NL (1) | NL1028599C2 (nl) |
| PA (1) | PA8627001A1 (nl) |
| TW (1) | TW200533351A (nl) |
| WO (1) | WO2005092860A1 (nl) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0516313D0 (en) | 2005-08-08 | 2005-09-14 | Argenta Discovery Ltd | Azole derivatives and their uses |
| KR20080036632A (ko) | 2005-08-08 | 2008-04-28 | 아젠터 디스커버리 리미티드 | 바이시클로[2.2.1]헵트-7-일아민 유도체 및 이들의 용도 |
| GB0601951D0 (en) | 2006-01-31 | 2006-03-15 | Novartis Ag | Organic compounds |
| AU2009203693B2 (en) | 2008-01-11 | 2012-06-07 | Novartis Ag | Pyrimidines as kinase inhibitors |
| US8236786B2 (en) | 2008-08-07 | 2012-08-07 | Pulmagen Therapeutics (Inflammation) Limited | Respiratory disease treatment |
| EA019441B1 (ru) | 2008-12-30 | 2014-03-31 | Палмаджен Терепьютикс (Инфлеммейшн) Лимитед | Сульфонамиды, предназначенные для лечения респираторных нарушений |
| WO2010150014A1 (en) | 2009-06-24 | 2010-12-29 | Pulmagen Therapeutics (Inflammation) Limited | 5r- 5 -deuterated glitazones for respiratory disease treatment |
| GB0918924D0 (en) | 2009-10-28 | 2009-12-16 | Vantia Ltd | Azaindole derivatives |
| GB0918923D0 (en) | 2009-10-28 | 2009-12-16 | Vantia Ltd | Aminothiazole derivatives |
| GB0918922D0 (en) | 2009-10-28 | 2009-12-16 | Vantia Ltd | Aminopyridine derivatives |
| WO2011098746A1 (en) | 2010-02-09 | 2011-08-18 | Pulmagen Therapeutics (Inflammation) Limited | Crystalline acid addition salts of ( 5r) -enanti0mer of pioglitazone |
| GB201002243D0 (en) | 2010-02-10 | 2010-03-31 | Argenta Therapeutics Ltd | Respiratory disease treatment |
| GB201002224D0 (en) | 2010-02-10 | 2010-03-31 | Argenta Therapeutics Ltd | Respiratory disease treatment |
| WO2012034095A1 (en) | 2010-09-09 | 2012-03-15 | Irm Llc | Compounds and compositions as trk inhibitors |
| UY33597A (es) | 2010-09-09 | 2012-04-30 | Irm Llc | Compuestos y composiciones como inhibidores de la trk |
| SG192795A1 (en) | 2011-02-25 | 2013-09-30 | Irm Llc | Compounds and compositions as trk inhibitors |
| MA44037B1 (fr) * | 2016-06-06 | 2020-03-31 | Arena Pharm Inc | Modulateurs du récepteur adrénergique bêta 3 utile dans le traitement ou la prévention de troubles associés à ceux-ci |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3700681A (en) * | 1971-02-16 | 1972-10-24 | Pfizer | 2-hydroxymethyl-3-hydroxy-6-(1-hydroxy-2-aminoethyl)pyridines |
| EP0220054A3 (en) * | 1985-10-16 | 1987-12-02 | Glaxo Group Limited | Ethanolamine derivatives |
| ATE247641T1 (de) * | 1996-11-14 | 2003-09-15 | Pfizer | Pyridin-zwischenprodukte, verwendbar zur herstellung von beta-adrenergischen rezeptor- agonisten |
| TWI249515B (en) * | 2001-11-13 | 2006-02-21 | Theravance Inc | Aryl aniline beta2 adrenergic receptor agonists |
| EP1477167A1 (en) * | 2003-05-15 | 2004-11-17 | Pfizer Limited | [(2-hydroxy-2-(4-hydroxy-3-hydroxymethylphenyl)-ethylamino)-propyl] phenyl derivatives as beta2 agonists |
-
2005
- 2005-03-11 WO PCT/IB2005/000669 patent/WO2005092860A1/en active Application Filing
- 2005-03-21 AR ARP050101096A patent/AR048322A1/es unknown
- 2005-03-21 TW TW094108630A patent/TW200533351A/zh unknown
- 2005-03-22 NL NL1028599A patent/NL1028599C2/nl not_active IP Right Cessation
- 2005-03-23 PA PA20058627001A patent/PA8627001A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PA8627001A1 (es) | 2006-05-16 |
| WO2005092860A1 (en) | 2005-10-06 |
| NL1028599C2 (nl) | 2006-01-03 |
| AR048322A1 (es) | 2006-04-19 |
| TW200533351A (en) | 2005-10-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NL1028599A1 (nl) | Verbindingen voor de behandeling van ziekten. | |
| NL1028598A1 (nl) | Imidazoolverbindingen voor de behandeling van neurodegeneratieve ziekten. | |
| NL1028086A1 (nl) | Sulfonamidederivaten voor de behandeling van ziekten. | |
| NL1028087A1 (nl) | Sulfonamiderivaten voor de behandeling van ziekten. | |
| NL1026329A1 (nl) | 2-Amino-pyridinederivaten toepasbaar voor de behandeling van ziekten. | |
| NL1024499A1 (nl) | Thiazoolverbindingen voor de behandeling van neurodegeneratieve stoornissen. | |
| NL1026327A1 (nl) | 2-Amino-pyridinederivaten toepasbaar voor de behandeling van ziekten. | |
| NL1026203A1 (nl) | Verbindingen toepasbaar voor de behandeling van ziekten. | |
| IL227841A0 (en) | Dihydropyridinones for the treatment of cancer | |
| NL1026892A1 (nl) | ó1,8!Naftyridin-2-onen en verwante verbindingen voor de behandeling van schizofrenie. | |
| NL1030418A1 (nl) | Azabenzoxazolen voor de behandeling van CZS-stoornissen. | |
| NL1028664A1 (nl) | Sulfonamideverbindingen voor de behandeling van neurodegeneratieve ziekten. | |
| NL1033562A1 (nl) | Tetrahydropyridoazepine-8-onen en verwante verbindingen voor de behandeling van schizofrenie. | |
| ITRM20050179A1 (it) | Composizione impiegabile per il trattamento delle patologie paradontali. | |
| NL1032552C2 (nl) | Imidazoolverbindingen voor de behandeling van neurologische stoornissen. | |
| GB0400802D0 (en) | Compounds for the treatment of disease | |
| NL1030417A1 (nl) | Azabenzoxazolen voor de behandeling van aandoeningen van het CZS. | |
| IL190182A0 (en) | 2-aminoalcohols for the treatment of neurodegenerative diseases | |
| ZA200606780B (en) | Compounds for the treatment of diseases | |
| NL1028600A1 (nl) | Verbindingen voor de behandeling van ziekten. | |
| NL1028597A1 (nl) | Formamidederivaten voor de behandeling van ziekten. | |
| NL1028559A1 (nl) | Verbindingen die bruikbaar zijn voor de behandeling van ziekten | |
| GB0425073D0 (en) | Compounds for the treatment of diseases | |
| GB0420867D0 (en) | Compounds for the treatment of diseases | |
| GB0415352D0 (en) | Compounds for the treatment of disease |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AD1A | A request for search or an international type search has been filed | ||
| RD2N | Patents in respect of which a decision has been taken or a report has been made (novelty report) |
Effective date: 20051102 |
|
| PD2B | A search report has been drawn up | ||
| VD1 | Lapsed due to non-payment of the annual fee |
Effective date: 20091001 |